Johannes Gutenberg-Universität Mainz
- 6131/39-0
Huber, Yvonne; Schattenberg, Joern M.
The new Focus on Metabolic Liver Diseases at UM Mainz is introducedGASTROENTEROLOGE. Bd. 15. H. 4. 2020 S. 343-345
Schirkonyer, V; Keilmann, A.; Harmuth, C. et al.
The new Mainz speech test for children aged 3-7 years (MATCH) Design, standardization, and validation. German versionHNO. Bd. 68. H. 7. 2020 S. 526-533
Riegel, Kristina; Rajalingam, Krishnaraj
The non-linearity of RAF-MEK signaling in dendritic cellsCELL CYCLE. Bd. 19. H. 18. 2020 S. 2249-2259
Drenth, Joost P. H.; Schattenberg, Joern M.
The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future successEXPERT OPINION ON INVESTIGATIONAL DRUGS. Bd. 29. H. 12. 2020 S. 1365-1375
Konstantinides, Stavros V.
The optimal imaging test for diagnosis of acute pulmonary embolism: a second chance for lung scintigraphy?EUROPEAN RESPIRATORY JOURNAL. Bd. 55. H. 6. 2020
Kriege, Marc; Heid, Florian; Alflen, Christian et al.
The Orogastric Tube Guide (R) as a novel strategy for gastric tube insertion: a prospective, randomized controlled clinical trialMINERVA ANESTESIOLOGICA. Bd. 86. H. 4. 2020 S. 416-422
van den Boom, Johannes; Hensel, Astrid; Trusch, Franziska et al.
The other side of the corona: nanoparticles inhibit the protease taspase1 in a size-dependent mannerNANOSCALE. Bd. 12. H. 37. 2020 S. 19093-19103
Francque, Sven M.; Bedossa, Pierre; Ratziu, Vlad et al.
THE PANPPAR AGONIST LANIFIBRANOR INDUCES BOTH RESOLUTION OF NASH AND REGRESSION OF FIBROSIS AFTER 24 WEEKS OF TREATMENT IN NON-CIRRHOTIC NASH: RESULTS OF THE NATIVE PHASE 2b TRIALHEPATOLOGY. Bd. 72. 2020 S. 9A-11A
Ernst, Mareike
The past is prologue? : Langzeitüberleben nach Krebs im Kindes- und Jugenalter aus psychosomatischer PerspektiveMainz: Univ. 2020 0 S.
Doering, Jan Henje; Saffari, Afshin; Bast, Thomas et al.
The Phenotypic Spectrum of PRRT2-Associated Paroxysmal Neurologic Disorders in ChildhoodBIOMEDICINES. Bd. 8. H. 11. 2020